Researchers performed a scoping review of 2024 original studies and recent reviews to identify emerging molecular biomarkers that could predict or enable earlier diagnosis of psoriatic arthritis (PsA) in patients with psoriasis (PsO).
Researchers performed a scoping review of 2024 original studies and recent reviews to identify emerging molecular biomarkers that could predict or enable earlier diagnosis of psoriatic arthritis (PsA) in patients with psoriasis (PsO).